======= SUPT20H ======= == Gene Information == * **Official Symbol**: SUPT20H * **Official Name**: SPT20 homolog, SAGA complex component * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55578|55578]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NEM7|Q8NEM7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SUPT20H&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SUPT20H|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613417|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Required for MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) activation during gastrulation. Required for down- regulation of E-cadherin during gastrulation by regulating E- cadherin protein level downstream from NCK-interacting kinase (NIK) and independently of the regulation of transcription by FGF signaling and Snail (By similarity). Required for starvation- induced ATG9A trafficking during autophagy. {ECO:0000250, ECO:0000269|PubMed:19893488}. |Spt20| |SAGA-type complex| |SAGA complex| |transcription coregulator activity| |fibrillar center| |gastrulation| |process utilizing autophagic mechanism| |autophagy| |embryonic morphogenesis| |embryo development| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-1.83| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.81| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.8| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.98| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|2.12| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|2.19| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.23| |[[:results:exp34|Rotenone 20μM R00 exp34]]|2.43| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|3.17| ^Gene^Correlation^ |[[:human genes:t:taf6l|TAF6L]]|0.568| |[[:human genes:t:tada1|TADA1]]|0.547| |[[:human genes:t:tada2b|TADA2B]]|0.517| |[[:human genes:s:supt7l|SUPT7L]]|0.487| |[[:human genes:t:taf5l|TAF5L]]|0.479| |[[:human genes:c:ccdc101|CCDC101]]|0.473| |[[:human genes:t:tada3|TADA3]]|0.432| |[[:human genes:m:med13|MED13]]|0.431| |[[:human genes:m:mllt1|MLLT1]]|0.422| |[[:human genes:s:smarcd1|SMARCD1]]|0.41| |[[:human genes:t:tle4|TLE4]]|0.408| |[[:human genes:m:med23|MED23]]|0.408| Global Fraction of Cell Lines Where Essential: 12/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|2/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|3/15| |prostate|1/1| |skin|0/24| |soft tissue|0/7| |thyroid|1/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1846 * **Expression level (log2 read counts)**: 6.29 {{:chemogenomics:nalm6 dist.png?nolink |}}